Contrast agent for early diagnostics and monitoring of progression of liver cancer (hepatocellular carcinoma)
2013 (English)Conference paper, Presentation (Refereed)
Place, publisher, year, edition, pages
Medical Laboratory and Measurements Technologies Medical Materials
IdentifiersURN: urn:nbn:se:kth:diva-137649OAI: oai:DiVA.org:kth-137649DiVA: diva2:679297
Nanoparticles for Early Diagnostics of Inflammatory Diseases: new approaches in the field of soft and hard nanoparticle, 20-21 November 2013, Lisboa, Portugal.
QC 201406182013-12-142013-12-142014-06-18Bibliographically approved